Institute for Molecular Cardiovascular Research, University Hospital Aachen, Medical Faculty, Rheinisch-Westfälische Technische Hochschule, Aachen, Germany.
Exp Cell Res. 2011 Mar 10;317(5):655-63. doi: 10.1016/j.yexcr.2010.11.014. Epub 2010 Dec 10.
It is generally accepted that G-protein coupled receptors (GPCR), like chemokine receptors, form dimers or higher order oligomers. Such homo- and heterophilic interactions have been identified not only among and between chemokine receptors of CC- or CXC-subfamilies, but also between chemokine receptors and other classes of GPCR, like the opioid receptors. Oligomerization affects different aspects of receptor physiology, like ligand affinity, signal transduction and the mode of internalization, in turn influencing physiologic processes such as cell activation and migration. As particular chemokine receptor pairs exert specific modulating effects on their individual functions, they might play particular roles in various disease types, such as cancer. Hence, chemokine receptor heteromers might represent attractive therapeutic targets. This review highlights the state-of-the-art knowledge on the technical and functional aspects of chemokine receptor multimerization in chemokine signaling and biology.
普遍认为,G 蛋白偶联受体(GPCR)与趋化因子受体一样,形成二聚体或更高阶的寡聚体。这种同型和异型相互作用不仅存在于趋化因子受体的 CC-或 CXC 亚家族成员之间,也存在于趋化因子受体与其他类别的 GPCR 之间,如阿片受体。寡聚化会影响受体生理学的不同方面,如配体亲和力、信号转导和内化模式,进而影响细胞激活和迁移等生理过程。由于特定的趋化因子受体对其各自的功能具有特定的调节作用,它们可能在各种疾病类型中发挥特定的作用,如癌症。因此,趋化因子受体异源二聚体可能是有吸引力的治疗靶点。这篇综述强调了趋化因子受体在趋化因子信号转导和生物学中的多聚化的技术和功能方面的最新知识。